| Year |
Citation |
Score |
| 2021 |
Huang C, Zhu XD, Shen YH, Wu D, Ji Y, Ge NL, Chen LL, Tan CJ, Zhou J, Fan J, Sun HC. Organ specific responses to first-line lenvatinib plus anti-PD-1 antibodies in patients with unresectable hepatocellular carcinoma: a retrospective analysis. Biomarker Research. 9: 19. PMID 33743822 DOI: 10.1186/s40364-021-00274-z |
0.4 |
|
| 2021 |
Liu G, Sun J, Yang ZF, Zhou C, Zhou PY, Guan RY, Sun BY, Wang ZT, Zhou J, Fan J, Qiu SJ, Yi Y. Cancer-associated fibroblast-derived CXCL11 modulates hepatocellular carcinoma cell migration and tumor metastasis through the circUBAP2/miR-4756/IFIT1/3 axis. Cell Death & Disease. 12: 260. PMID 33707417 DOI: 10.1038/s41419-021-03545-7 |
0.4 |
|
| 2021 |
Han Y, Liu Q, Hou J, Gu Y, Zhang Y, Chen Z, Fan J, Zhou W, Qiu S, Zhang Y, Dong T, Li N, Jiang Z, Zhu H, Zhang Q, et al. Tumor-Induced Generation of Splenic Erythroblast-like Ter-Cells Promotes Tumor Progression. Cell. 184: 1392. PMID 33667369 DOI: 10.1016/j.cell.2020.02.036 |
0.4 |
|
| 2021 |
Zhang X, Hu B, Sun YF, Huang XW, Cheng JW, Huang A, Zeng HY, Qiu SJ, Cao Y, Fan J, Zhou J, Yang XR. Arsenic trioxide induces differentiation of cancer stem cells in hepatocellular carcinoma through inhibition of LIF/JAK1/STAT3 and NF-kB signaling pathways synergistically. Clinical and Translational Medicine. 11: e335. PMID 33634982 DOI: 10.1002/ctm2.335 |
0.4 |
|
| 2020 |
Zhou J, Sun H, Wang Z, Cong W, Wang J, Zeng M, Zhou W, Bie P, Liu L, Wen T, Han G, Wang M, Liu R, Lu L, Ren Z, ... ... Fan J, et al. Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition). Liver Cancer. 9: 682-720. PMID 33442540 DOI: 10.1159/000509424 |
0.4 |
|
| 2020 |
Yan J, Zhou B, Guo L, Chen Z, Zhang B, Liu S, Zhang W, Yu M, Xu Y, Xiao Y, Zhou J, Fan J, Li H, Ye Q. GOLM1 upregulates expression of PD-L1 through EGFR/STAT3 pathway in hepatocellular carcinoma. American Journal of Cancer Research. 10: 3705-3720. PMID 33294262 |
0.4 |
|
| 2020 |
Chen Z, Yu M, Yan J, Zhou B, Zhang W, Guo L, Zhang B, Liu S, Jin L, Zhou J, Fan J, Ye Q, Li H, Xiao Y, Xu Y. Association of intrinsic pathways with altered tumor immune infiltration in hepatocellular carcinoma: New targets for combining immune therapy. Clinical and Translational Medicine. 10: e219. PMID 33252850 DOI: 10.1002/ctm2.219 |
0.4 |
|
| 2020 |
Sun HC, Zhu XD, Zhou J, Gao Q, Shi YH, Ding ZB, Huang C, Qiu SJ, Ren N, Shi GM, Sun J, Ye QH, Huang XW, Yang XR, Fan J. Adjuvant apatinib treatment after resection of hepatocellular carcinoma with portal vein tumor thrombosis: a phase II trial. Annals of Translational Medicine. 8: 1301. PMID 33209881 DOI: 10.21037/atm-20-6181 |
0.4 |
|
| 2020 |
Zhou Q, Cai H, Xu MH, Ye Y, Li XL, Shi GM, Huang C, Zhu XD, Cai JB, Zhou J, Fan J, Ji Y, Sun HC, Shen YH. Do the existing staging systems for primary liver cancer apply to combined hepatocellular carcinoma-intrahepatic cholangiocarcinoma? Hepatobiliary & Pancreatic Diseases International : Hbpd Int. PMID 33160852 DOI: 10.1016/j.hbpd.2020.10.002 |
0.4 |
|
| 2020 |
Song F, Hu B, Cheng JW, Sun YF, Zhou KQ, Wang PX, Guo W, Zhou J, Fan J, Chen Z, Yang XR. Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma. Cell Death & Disease. 11: 573. PMID 32709873 DOI: 10.1038/s41419-020-02749-7 |
0.4 |
|
| 2020 |
Sun YF, Wang PX, Cheng JW, Gong ZJ, Huang A, Zhou KQ, Hu B, Gao PT, Cao Y, Qiu SJ, Zhou J, Fan J, Guo W, Yang XR. Postoperative circulating tumor cells: An early predictor of extrahepatic metastases in patients with hepatocellular carcinoma undergoing curative surgical resection. Cancer Cytopathology. PMID 32501632 DOI: 10.1002/cncy.22304 |
0.4 |
|
| 2020 |
Zhou B, Yan J, Guo L, Zhang B, Liu S, Yu M, Chen Z, Zhang K, Zhang W, Li X, Xu Y, Xiao Y, Zhou J, Fan J, Hung MC, et al. Hepatoma cell-intrinsic TLR9 activation induces immune escape through PD-L1 upregulation in hepatocellular carcinoma. Theranostics. 10: 6530-6543. PMID 32483468 DOI: 10.7150/thno.44417 |
0.4 |
|
| 2020 |
Qu WF, Zhou PY, Liu WR, Tian MX, Jin L, Jiang XF, Wang H, Tao CY, Fang Y, Zhou YF, Song SS, Ding ZB, Peng YF, Dai Z, Qiu SJ, ... ... Fan J, et al. Age-adjusted Charlson Comorbidity Index predicts survival in intrahepatic cholangiocarcinoma patients after curative resection. Annals of Translational Medicine. 8: 487. PMID 32395531 DOI: 10.21037/atm.2020.03.23 |
0.4 |
|
| 2020 |
Ding GY, Zhu XD, Ji Y, Shi GM, Shen YH, Zhou J, Fan J, Sun HC, Huang C. Serum PON1 as a biomarker for the estimation of microvascular invasion in hepatocellular carcinoma. Annals of Translational Medicine. 8: 204. PMID 32309351 DOI: 10.21037/atm.2020.01.44 |
0.4 |
|
| 2020 |
Hu JW, Ding GY, Fu PY, Tang WG, Sun QM, Zhu XD, Shen YH, Zhou J, Fan J, Sun HC, Huang C. Identification of FOS as a Candidate Risk Gene for Liver Cancer by Integrated Bioinformatic Analysis. Biomed Research International. 2020: 6784138. PMID 32280695 DOI: 10.1155/2020/6784138 |
0.4 |
|
| 2020 |
Li XL, Zhu XD, Xiao N, Liu XF, Xu B, Shi GM, Huang C, Shen YH, Cai JB, Zhou J, Fan J, Sun HC. A prospective study of the effect of terlipressin on portal vein pressure and clinical outcomes after hepatectomy: A pilot study. Surgery. PMID 32113581 DOI: 10.1016/j.surg.2020.01.013 |
0.4 |
|
| 2020 |
Huang JL, Fu YP, Gan W, Liu G, Zhou PY, Zhou C, Sun BY, Guan RY, Zhou J, Fan J, Yi Y, Qiu SJ. Hepatic stellate cells promote the progression of hepatocellular carcinoma through microRNA-1246-RORα-Wnt/β-Catenin axis. Cancer Letters. PMID 32061951 DOI: 10.1016/j.canlet.2020.02.012 |
0.4 |
|
| 2020 |
Liu G, Yang ZF, Zhou PY, Zhou C, Guan RY, Sun BY, Fan J, Zhou J, Yi Y, Qiu SJ. ROR-α-1 inhibits the proliferation, invasion, and migration of hepatocellular carcinoma MHCC97H via downregulation of chemokine CXCL5. Cytokine. 129: 155004. PMID 32058275 DOI: 10.1016/j.cyto.2020.155004 |
0.4 |
|
| 2019 |
Zhou PY, Yang CP, Tang Z, Yi Y, Liu WR, Tian MX, Huang JL, Gan W, Jiang XF, Liu G, Wang H, Tao CY, Fang Y, Qu WF, Zhou C, ... ... Fan J, et al. Daily decrease of post-operative alpha-fetoprotein by 9% discriminates prognosis of HCC: A multicenter retrospective study. Aging. 11. PMID 31829979 DOI: 10.18632/aging.102513 |
0.4 |
|
| 2019 |
Hu JW, Yang ZF, Li J, Hu B, Luo CB, Zhu K, Dai Z, Cai JB, Zhan H, Hu ZQ, Hu J, Cao Y, Qiu SJ, Zhou J, Fan J, et al. TGM3 promotes epithelial-mesenchymal transition and hepatocellular carcinogenesis and predicts poor prognosis for patients after curative resection. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. PMID 31822388 DOI: 10.1016/j.dld.2019.10.010 |
0.4 |
|
| 2019 |
Zhou B, Guo L, Zhang B, Liu S, Zhang K, Yan J, Zhang W, Yu M, Chen Z, Xu Y, Xiao Y, Zhou J, Fan J, Li H, Ye Q. Disulfiram combined with copper induces immunosuppression via PD-L1 stabilization in hepatocellular carcinoma. American Journal of Cancer Research. 9: 2442-2455. PMID 31815045 |
0.4 |
|
| 2019 |
Yu MC, Liu JX, Ma XL, Fu PY, Sun HX, Tang WG, Yang ZF, Qiu SJ, Zhou J, Fan J, Xu Y. Differential network analysis depicts regulatory mechanisms for hepatocellular carcinoma from diverse backgrounds. Future Oncology (London, England). PMID 31729887 DOI: 10.2217/fon-2019-0275 |
0.4 |
|
| 2019 |
Tang Z, Liu WR, Zhou PY, Ding ZB, Jiang XF, Wang H, Tian MX, Tao CY, Fang Y, Qu WF, Dai Z, Qiu SJ, Zhou J, Fan J, Shi YH. Prognostic Value and Predication Model of Microvascular Invasion in Patients with Intrahepatic Cholangiocarcinoma. Journal of Cancer. 10: 5575-5584. PMID 31632502 DOI: 10.7150/jca.32199 |
0.4 |
|
| 2019 |
Gao Y, Wang PX, Cheng JW, Sun YF, Hu B, Guo W, Zhou KQ, Yin Y, Li YC, Wang J, Huang JF, Qiu SJ, Zhou J, Fan J, Yang XR. Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: A propensity score-matched survival analysis. Cancer Medicine. PMID 31566899 DOI: 10.1002/cam4.2556 |
0.4 |
|
| 2019 |
Hu B, Cheng JW, Hu JW, Li H, Ma XL, Tang WG, Sun YF, Guo W, Huang A, Zhou KQ, Gao PT, Cao Y, Qiu SJ, Zhou J, Fan J, et al. KPNA3 Confers Sorafenib Resistance to Advanced Hepatocellular Carcinoma via TWIST Regulated Epithelial-Mesenchymal Transition. Journal of Cancer. 10: 3914-3925. PMID 31417635 DOI: 10.7150/jca.31448 |
0.4 |
|
| 2019 |
Lu JC, Zeng HY, Sun QM, Meng QN, Huang XY, Zhang PF, Yang X, Peng R, Gao C, Wei CY, Shen YH, Cai JB, Dong RZ, Shi YH, Sun HC, ... ... Fan J, et al. Distinct PD-L1/PD1 Profiles and Clinical Implications in Intrahepatic Cholangiocarcinoma Patients with Different Risk Factors. Theranostics. 9: 4678-4687. PMID 31367249 DOI: 10.7150/thno.36276 |
0.4 |
|
| 2019 |
Cai J, Chen L, Zhang Z, Zhang X, Lu X, Liu W, Shi G, Ge Y, Gao P, Yang Y, Ke A, Xiao L, Dong R, Zhu Y, Yang X, ... ... Fan J, et al. Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma. Gut. PMID 31358576 DOI: 10.1136/gutjnl-2019-318882 |
0.4 |
|
| 2019 |
Hu B, Li H, Guo W, Sun YF, Zhang X, Tang WG, Yang LX, Xu Y, Tang XY, Ding GH, Qiu SJ, Zhou J, Li YX, Fan J, Yang XR. Establishment of a hepatocellular carcinoma patient-derived xenograft platform and its application in biomarker identification. International Journal of Cancer. PMID 31310010 DOI: 10.1002/ijc.32564 |
0.4 |
|
| 2019 |
Tian MX, Luo LP, Liu WR, Deng W, Yin JC, Jin L, Jiang XF, Zhou YF, Qu WF, Tang Z, Wang H, Tao CY, Fang Y, Qiu SJ, Zhou J, ... ... Fan J, et al. Development and validation of a prognostic score predicting recurrence in resected combined hepatocellular cholangiocarcinoma. Cancer Management and Research. 11: 5187-5195. PMID 31239773 DOI: 10.2147/CMAR.S195964 |
0.4 |
|
| 2019 |
Tian MX, Liu WR, Wang H, Zhou YF, Jin L, Jiang XF, Tao CY, Tang Z, Zhou PY, Fang Y, Qu WF, Ding ZB, Peng YF, Dai Z, Qiu SJ, ... ... Fan J, et al. Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma. Bmc Medicine. 17: 106. PMID 31164128 DOI: 10.1186/s12916-019-1341-6 |
0.4 |
|
| 2019 |
Yang X, Miao BS, Wei CY, Dong RZ, Gao PT, Zhang XY, Lu JC, Gao C, Wang XY, Sun HC, Zhou J, Fan J, Ke AW, Shi GM, Cai JB. LSH promotes the growth and invasion of HCC via transcriptional regulation of CENPF expression. Cancer Science. PMID 31066149 DOI: 10.1111/cas.14037 |
0.4 |
|
| 2019 |
Ma XL, Shen MN, Hu B, Wang BL, Yang WJ, Lv LH, Wang H, Zhou Y, Jin AL, Sun YF, Zhang CY, Qiu SJ, Pan BS, Zhou J, Fan J, et al. CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis. Journal of Hematology & Oncology. 12: 37. PMID 30971294 DOI: 10.1186/s13045-019-0724-7 |
0.4 |
|
| 2019 |
Lv Y, Han X, Xu XF, Ji Y, Zhou YH, Sun HC, Zhou J, Fan J, Lou WH, Huang C. Risk factors affecting prognosis in metachronous liver metastases from WHO classification G1 and G2 gastroenteropancreatic neuroendocrine tumors after initial R0 surgical resection. Bmc Cancer. 19: 335. PMID 30961559 DOI: 10.1186/s12885-019-5457-z |
0.4 |
|
| 2019 |
Gong ZJ, Cheng JW, Gao PT, Huang A, Sun YF, Zhou KQ, Hu B, Qiu SJ, Zhou J, Fan J, Yang XR. Clinical Characteristics and Prognostic Factors of Patients with Intrahepatic Cholangiocarcinoma with Fever: A Propensity Score Matching Analysis. The Oncologist. PMID 30910867 DOI: 10.1634/theoncologist.2018-0268 |
0.4 |
|
| 2019 |
Li XL, Zhu XD, Cai H, Li Y, Zhou J, Fan J, Tang ZY, Sun HC. Postoperative α-fetoprotein response predicts tumor recurrence and survival after hepatectomy for hepatocellular carcinoma: A propensity score matching analysis. Surgery. PMID 30846192 DOI: 10.1016/j.surg.2019.01.009 |
0.4 |
|
| 2019 |
Dong RZ, Yang X, Zhang XY, Gao PT, Ke AW, Sun HC, Zhou J, Fan J, Cai JB, Shi GM. Predicting overall survival of patients with hepatocellular carcinoma using a three-category method based on DNA methylation and machine learning. Journal of Cellular and Molecular Medicine. PMID 30784182 DOI: 10.1111/jcmm.14231 |
0.4 |
|
| 2018 |
Zhang XY, Gao PT, Yang X, Cai JB, Ding GY, Zhu XD, Ji Y, Shi GM, Shen YH, Zhou J, Fan J, Sun HC, Yang LX, Huang C. Reduced selenium-binding protein 1 correlates with a poor prognosis in intrahepatic cholangiocarcinoma and promotes the cell epithelial-mesenchymal transition. American Journal of Translational Research. 10: 3567-3578. PMID 30662608 |
0.4 |
|
| 2018 |
Gan W, Zhang MX, Wang JX, Fu YP, Huang JL, Yi Y, Jing CY, Fan J, Zhou J, Qiu SJ. Prognostic impact of lactic dehydrogenase to albumin ratio in hepatocellular carcinoma patients with Child-Pugh I who underwent curative resection: a prognostic nomogram study. Cancer Management and Research. 10: 5383-5394. PMID 30464634 DOI: 10.2147/CMAR.S176317 |
0.4 |
|
| 2018 |
Huang C, Zhu XD, Shi GM, Shen YH, Ding GY, Cai JB, Zhou J, Fan J, Sun HC. Dexamethasone for postoperative hyperbilirubinemia in patients after liver resection: An open-label, randomized controlled trial. Surgery. PMID 30348460 DOI: 10.1016/j.surg.2018.09.002 |
0.4 |
|
| 2018 |
Zhou J, Sun HC, Wang Z, Cong WM, Wang JH, Zeng MS, Yang JM, Bie P, Liu LX, Wen TF, Han GH, Wang MQ, Liu RB, Lu LG, Ren ZG, ... ... Fan J, et al. Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition). Liver Cancer. 7: 235-260. PMID 30319983 DOI: 10.1159/000488035 |
0.4 |
|
| 2018 |
Chen XX, Yin Y, Cheng JW, Huang A, Hu B, Zhang X, Sun YF, Wang J, Wang YP, Ji Y, Qiu SJ, Fan J, Zhou J, Yang XR. BAP1 acts as a tumor suppressor in intrahepatic cholangiocarcinoma by modulating the ERK1/2 and JNK/c-Jun pathways. Cell Death & Disease. 9: 1036. PMID 30305612 DOI: 10.1038/s41419-018-1087-7 |
0.4 |
|
| 2018 |
Jing CY, Fu YP, Huang JL, Zhang MX, Yi Y, Gan W, Xu X, Shen HJ, Lin JJ, Zheng SS, Zhang J, Zhou J, Fan J, Ren ZG, Qiu SJ, et al. Prognostic Nomogram Based on Histological Characteristics of Fibrotic Tumor Stroma in Patients Who Underwent Curative Resection for Intrahepatic Cholangiocarcinoma. The Oncologist. PMID 30257891 DOI: 10.1634/theoncologist.2017-0439 |
0.4 |
|
| 2018 |
Gao PT, Ding GY, Yang X, Dong RZ, Hu B, Zhu XD, Cai JB, Ji Y, Shi GM, Shen YH, Zhou J, Fan J, Sun HC, Huang C. Invasive potential of hepatocellular carcinoma is enhanced by loss of selenium-binding protein 1 and subsequent upregulation of CXCR4. American Journal of Cancer Research. 8: 1040-1049. PMID 30034941 |
0.4 |
|
| 2018 |
Ling CQ, Fan J, Lin HS, Shen F, Xu ZY, Lin LZ, Qin SK, Zhou WP, Zhai XF, Li B, Zhou QH. Clinical practice guidelines for the treatment of primary liver cancer with integrative traditional Chinese and Western medicine. Journal of Integrative Medicine. PMID 29891180 DOI: 10.1016/j.joim.2018.05.002 |
0.4 |
|
| 2018 |
He S, Hu B, Li C, Lin P, Tang WG, Sun YF, Feng FY, Guo W, Li J, Xu Y, Yao QL, Zhang X, Qiu SJ, Zhou J, Fan J, et al. PDXliver: a database of liver cancer patient derived xenograft mouse models. Bmc Cancer. 18: 550. PMID 29743053 DOI: 10.1186/s12885-018-4459-6 |
0.4 |
|
| 2018 |
Han Y, Liu Q, Hou J, Gu Y, Zhang Y, Chen Z, Fan J, Zhou W, Qiu S, Zhang Y, Dong T, Li N, Jiang Z, Zhu H, Zhang Q, et al. Tumor-Induced Generation of Splenic Erythroblast-like Ter-Cells Promotes Tumor Progression. Cell. PMID 29606356 DOI: 10.1016/j.cell.2018.02.061 |
0.4 |
|
| 2018 |
Tao CY, Liu WR, Jin L, Tang Z, Tian MX, Jiang XF, Wang H, Zhou PY, Fang Y, Ding ZB, Peng YF, Dai Z, Qiu SJ, Zhou J, Fan J, et al. Surgical Treatment of Combined Hepatocellular-Cholangiocarcinoma is as Effective in Elderly Patients as it is in Younger Patients: A Propensity Score Matching Analysis. Journal of Cancer. 9: 1106-1112. PMID 29581790 DOI: 10.7150/jca.23921 |
0.4 |
|
| 2018 |
Tian MX, He WJ, Liu WR, Yin JC, Jin L, Tang Z, Jiang XF, Wang H, Zhou PY, Tao CY, Ding ZB, Peng YF, Dai Z, Qiu SJ, Zhou J, ... Fan J, et al. A Novel Risk prediction Model for Patients with Combined Hepatocellular-Cholangiocarcinoma. Journal of Cancer. 9: 1025-1032. PMID 29581782 DOI: 10.7150/jca.23229 |
0.4 |
|
| 2018 |
Gan W, Huang JL, Zhang MX, Fu YP, Yi Y, Jing CY, Fan J, Zhou J, Qiu SJ. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection. Journal of Surgical Oncology. PMID 29572833 DOI: 10.1002/jso.25046 |
0.4 |
|
| 2018 |
Zhai XF, Liu XL, Shen F, Fan J, Ling CQ. Traditional herbal medicine prevents postoperative recurrence of small hepatocellular carcinoma: A randomized controlled study. Cancer. PMID 29499082 DOI: 10.1002/cncr.30915 |
0.4 |
|
| 2018 |
Hu B, Ding GY, Fu PY, Zhu XD, Ji Y, Shi GM, Shen YH, Cai JB, Yang Z, Zhou J, Fan J, Sun HC, Kuang M, Huang C. NOD-like receptor X1 functions as a tumor suppressor by inhibiting epithelial-mesenchymal transition and inducing aging in hepatocellular carcinoma cells. Journal of Hematology & Oncology. 11: 28. PMID 29482578 DOI: 10.1186/s13045-018-0573-9 |
0.4 |
|
| 2018 |
Zhou J, Wang Z, Ren Z, Chen Y, Hu J, Yang GH, Yu L, Yang XR, Huang A, Zhang X, Zhou SL, Sun HC, Wang YH, Ge NL, Xu XY, ... ... Fan J, et al. Adjuvant transarterial chemoembolization for HBV-related hepatocellular carcinoma after resection: a randomized controlled study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29420221 DOI: 10.1158/1078-0432.CCR-17-2899 |
0.4 |
|
| 2018 |
Fan J, Guo W, Sun YF, Shen M, Ma XL, Wu J, Zhang C, Zhou Y, Xu Y, Hu B, Zhang M, Wang G, Chen WQ, Guo L, Lu R, et al. Circulating tumor cells with stem-like phenotypes for diagnosis, prognosis and therapeutic response evaluation in hepatocellular carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29374055 DOI: 10.1158/1078-0432.CCR-17-1753 |
0.4 |
|
| 2017 |
Hu J, Chen FY, Zhou KQ, Zhou C, Cao Y, Sun HC, Fan J, Zhou J, Wang Z. Intrahepatic cholangiocarcinoma patients without indications of lymph node metastasis not benefit from lymph node dissection. Oncotarget. 8: 113817-113827. PMID 29371948 DOI: 10.18632/oncotarget.22852 |
0.4 |
|
| 2017 |
Gao PT, Cheng JW, Gong ZJ, Hu B, Sun YF, Cao Y, Qiu SJ, Zhou J, Fan J, Yang XR. Low SLC29A1 expression is associated with poor prognosis in patients with hepatocellular carcinoma. American Journal of Cancer Research. 7: 2465-2477. PMID 29312800 |
0.4 |
|
| 2017 |
Huang JL, Fu YP, Jing CY, Yi Y, Sun J, Gan W, Lu ZF, Zhou J, Fan J, Qiu SJ. A novel and validated prognostic nomogram based on liver fibrosis and tumor burden for patients with hepatocellular carcinoma after curative resection. Journal of Surgical Oncology. PMID 29165812 DOI: 10.1002/jso.24895 |
0.4 |
|
| 2017 |
Dong ZR, Zou J, Sun D, Shi GM, Ke AW, Cai JB, Sun HC, Qiu SJ, Li T, Zhou J, Zhi XT, Fan J. Preoperative Albumin-Bilirubin Score for Postoperative Solitary Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh A Cirrhosis. Journal of Cancer. 8: 3862-3867. PMID 29151974 DOI: 10.7150/jca.21313 |
0.4 |
|
| 2017 |
Zhou PY, Tang Z, Liu WR, Tian MX, Jin L, Jiang XF, Wang H, Tao CY, Ding ZB, Peng YF, Qiu SJ, Dai Z, Zhou J, Fan J, Shi YH. Perioperative blood transfusion does not affect recurrence-free and overall survivals after curative resection for intrahepatic cholangiocarcinoma: a propensity score matching analysis. Bmc Cancer. 17: 762. PMID 29137600 DOI: 10.1186/s12885-017-3745-z |
0.4 |
|
| 2017 |
Sun HC, Xie L, Yang XR, Li W, Yu J, Zhu XD, Xia Y, Zhang T, Xu Y, Hu B, Du LP, Zeng LY, Ouyang J, Zhang W, Song TQ, ... ... Fan J, et al. Shanghai Score: A Prognostic and Adjuvant Treatment-evaluating System Constructed for Chinese Patients with Hepatocellular Carcinoma after Curative Resection. Chinese Medical Journal. 130: 2650-2660. PMID 29133751 DOI: 10.4103/0366-6999.218019 |
0.4 |
|
| 2017 |
Sun Y, Guo W, Xu Y, Shi YH, Gong Z, Ji Y, Du M, Zhang X, Hu B, Huang A, Chen GG, Lai PBS, Cao Y, Qiu SJ, Zhou J, ... ... Fan J, et al. Circulating Tumors Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29070526 DOI: 10.1158/1078-0432.CCR-17-1063 |
0.4 |
|
| 2017 |
Liu X, Wang Z, Chen Z, Liu L, Ma L, Dong L, Zhang Z, Zhang S, Yang L, Shi J, Fan J, Wang X, Gao Q. Efficacy and Safety of Transcatheter Arterial Chemoembolization and Transcatheter Arterial Chemotherapy Infusion in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Oncology Research. PMID 28911342 DOI: 10.3727/096504017X15051752095738 |
0.4 |
|
| 2017 |
Shen Y, Zhou C, Zhu G, Shi G, Zhu X, Huang C, Zhou J, Fan J, Ding H, Ren N, Sun HC. Liver Stiffness Assessed by Shear Wave Elastography Predicts Postoperative Liver Failure in Patients with Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. PMID 28510795 DOI: 10.1007/s11605-017-3443-9 |
0.4 |
|
| 2017 |
Wang WM, Xu Y, Wang YH, Sun HX, Sun YF, He YF, Zhu QF, Hu B, Zhang X, Xia JL, Qiu SJ, Zhou J, Yang XR, Fan J. HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma. Oncotarget. PMID 28454092 DOI: 10.18632/oncotarget.17004 |
0.4 |
|
| 2017 |
Fu YP, Yi Y, Huang JL, Jing CY, Sun J, Ni XC, Lu ZF, Cao Y, Zhou J, Fan J, Qiu SJ. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection. The Oncologist. PMID 28438885 DOI: 10.1634/theoncologist.2016-0231 |
0.4 |
|
| 2017 |
Jing CY, Fu YP, Zheng SS, Yi Y, Shen HJ, Huang JL, Xu X, Lin JJ, Zhou J, Fan J, Ren ZG, Qiu SJ, Zhang BH. Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection. Medicine. 96: e6140. PMID 28296727 DOI: 10.1097/MD.0000000000006140 |
0.4 |
|
| 2017 |
Huang C, Zhu XD, Ji Y, Ding GY, Shi GM, Shen YH, Zhou J, Fan J, Sun HC. Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B. Bmc Cancer. 17: 58. PMID 28095820 DOI: 10.1186/s12885-017-3050-x |
0.4 |
|
| 2017 |
Jing CY, Fu YP, Shen HJ, Zheng SS, Lin JJ, Yi Y, Huang JL, Xu X, Zhang J, Zhou J, Fan J, Ren ZG, Qiu SJ, Zhang BH. Albumin to gamma-glutamyltransferase ratio as a prognostic indicator in intrahepatic cholangiocarcinoma after curative resection. Oncotarget. PMID 28076328 DOI: 10.18632/oncotarget.14530 |
0.4 |
|
| 2016 |
Jin L, Liu WR, Tian MX, Jiang XF, Wang H, Zhou PY, Ding ZB, Peng YF, Dai Z, Qiu SJ, Zhou J, Fan J, Shi YH. CCL24 contributes to HCC malignancy via RhoB- VEGFA-VEGFR2 angiogenesis pathway and indicates poor prognosis. Oncotarget. PMID 28042950 DOI: 10.18632/oncotarget.14095 |
0.4 |
|
| 2016 |
Luo X, Liao R, Hanley KL, Zhu HH, Malo KN, Hernandez C, Wei X, Varki NM, Alderson N, Chu C, Li S, Fan J, Loomba R, Qiu SJ, Feng GS. Dual Shp2 and Pten Deficiencies Promote Non-alcoholic Steatohepatitis and Genesis of Liver Tumor-Initiating Cells. Cell Reports. 17: 2979-2993. PMID 27974211 DOI: 10.1016/j.celrep.2016.11.048 |
0.4 |
|
| 2016 |
Gong ZJ, Guo W, Sun YF, Zhang X, Qiu SJ, Zhou J, Fan J, Yang XR. Prognostic value of fever grade combined with neutrophil percentage in hepatocellular carcinoma patients presenting fever as the initial manifestation. Oncotargets and Therapy. 9: 6281-6290. PMID 27789960 DOI: 10.2147/OTT.S109023 |
0.4 |
|
| 2016 |
Gao XH, Tian L, Wu J, Ma XL, Zhang CY, Zhou Y, Sun YF, Hu B, Qiu SJ, Zhou J, Fan J, Guo W, Yang XR. Circulating CD14(+) HLA-DR(-/low) myeloid-derived suppressor cells predicted early recurrence of hepatocellular carcinoma after surgery. Hepatology Research : the Official Journal of the Japan Society of Hepatology. PMID 27764536 DOI: 10.1111/hepr.12831 |
0.4 |
|
| 2016 |
Cai XY, Ni XC, Yi Y, He HW, Wang JX, Fu YP, Sun J, Zhou J, Cheng YF, Jin JJ, Fan J, Qiu SJ. Overexpression of CD39 in hepatocellular carcinoma is an independent indicator of poor outcome after radical resection. Medicine. 95: e4989. PMID 27749555 DOI: 10.1097/MD.0000000000004989 |
0.4 |
|
| 2016 |
Ma XL, Gao XH, Gong ZJ, Wu J, Tian L, Zhang CY, Zhou Y, Sun YF, Hu B, Qiu SJ, Zhou J, Fan J, Guo W, Yang XR. Apolipoprotein A1: a novel serum biomarker for predicting the prognosis of hepatocellular carcinoma after curative resection. Oncotarget. PMID 27683106 DOI: 10.18632/oncotarget.12203 |
0.4 |
|
| 2016 |
Liao R, Fu YP, Wang T, Deng ZG, Li DW, Fan J, Zhou J, Feng GS, Qiu SJ, Du CY. Metavir and FIB-4 scores are associated with patient prognosis after curative hepatectomy in hepatitis B virus-related hepatocellular carcinoma: a retrospective cohort study at two centers in China. Oncotarget. PMID 27662665 DOI: 10.18632/oncotarget.12152 |
0.4 |
|
| 2016 |
Li T, Wang SK, Zhi XT, Zhou J, Dong ZR, Zhang ZL, Sun HC, Ye QH, Fan J. Cholecystectomy is associated with higher risk of early recurrence and poorer survival after curative resection for early stage hepatocellular carcinoma. Scientific Reports. 6: 28229. PMID 27320390 DOI: 10.1038/srep28229 |
0.4 |
|
| 2016 |
Li J, Zhou J, Yang PH, Xia Y, Shi YH, Wu D, Lv G, Zheng W, Wang K, Wan XY, Lau WY, Wu MC, Fan J, Shen F. Nomograms for survival prediction in patients undergoing liver resection for hepatitis B virus related early stage hepatocellular carcinoma. European Journal of Cancer (Oxford, England : 1990). 62: 86-95. PMID 27232330 DOI: 10.1016/j.ejca.2016.04.011 |
0.4 |
|
| 2016 |
Fu YP, Yi Y, Cai XY, Sun J, Ni XC, He HW, Wang JX, Lu ZF, Huang JL, Cao Y, Zhou J, Fan J, Qiu SJ. Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection. British Journal of Cancer. PMID 27002937 DOI: 10.1038/bjc.2016.47 |
0.4 |
|
| 2016 |
Wang L, Fan J, Hitron JA, Son YO, Wise JT, Roy RV, Kim D, Dai J, Pratheeshkumar P, Zhang Z, Shi X. Cancer stem-like cells accumulated in nickel-induced malignant transformation. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 26962057 DOI: 10.1093/toxsci/kfw044 |
0.36 |
|
| 2016 |
Fu YP, Ni XC, Yi Y, Cai XY, He HW, Wang JX, Lu ZF, Han X, Cao Y, Zhou J, Fan J, Qiu SJ. A Novel and Validated Inflammation-Based Score (IBS) Predicts Survival in Patients With Hepatocellular Carcinoma Following Curative Surgical Resection: A STROBE-Compliant Article. Medicine. 95: e2784. PMID 26886627 DOI: 10.1097/MD.0000000000002784 |
0.4 |
|
| 2016 |
Gong ZJ, Guo W, Sun YF, Zhang X, Qiu SJ, Zhou J, Fan J, Yang XR. Prognostic value of fever grade combined with neutrophil percentage in hepatocellular carcinoma patients presenting fever as the initial manifestation Oncotargets and Therapy. 9: 6281-6290. DOI: 10.2147/OTT.S109023 |
0.4 |
|
| 2015 |
Wang Z, Liao BY, Qiu SJ, Sun HC, Yang XR, Zhou J, Fan J. Oxidized Regenerated Cellulose Reduces the Amount of Fluid Drainage after Liver Resection: A Randomized Prospective Clinical Trial. Hepatogastroenterology. 62: 951-4. PMID 26902035 |
0.4 |
|
| 2015 |
Ni XC, Yi Y, Fu YP, He HW, Cai XY, Wang JX, Zhou J, Cheng YF, Jin JJ, Fan J, Qiu SJ. Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular Carcinoma. Medicine. 94: e1486. PMID 26356714 DOI: 10.1097/MD.0000000000001486 |
0.4 |
|
| 2015 |
Liu WR, Jin L, Tian MX, Jiang XF, Yang LX, Ding ZB, Shen YH, Peng YF, Gao DM, Zhou J, Qiu SJ, Dai Z, Fan J, Shi YH. Caveolin-1 promotes tumor growth and metastasis via autophagy inhibition in hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology. PMID 26206578 DOI: 10.1016/j.clinre.2015.06.017 |
0.4 |
|
| 2015 |
Zhang X, Yang XR, Sun C, Hu B, Sun YF, Huang XW, Wang Z, He YF, Zeng HY, Qiu SJ, Cao Y, Fan J, Zhou J. Promyelocytic leukemia protein induces arsenic trioxide resistance through regulation of aldehyde dehydrogenase 3 family member A1 in hepatocellular carcinoma. Cancer Letters. 366: 112-22. PMID 26118777 DOI: 10.1016/j.canlet.2015.06.014 |
0.4 |
|
| 2015 |
Li T, Wang SK, Zhou J, Sun HC, Qiu SJ, Ye QH, Wang L, Fan J. Positive HBcAb is associated with higher risk of early recurrence and poorer survival after curative resection of HBV-related HCC. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 26104132 DOI: 10.1111/liv.12898 |
0.4 |
|
| 2015 |
Qiu SJ, Zhou ZG, Shen F, Li AJ, Chen MS, Ying MG, Chen Z, Zhang YX, Sun HC, Fan J. A multicenter, randomized, observation-controlled clinical trial to evaluate the efficacy and safety of thymalfasin adjuvant therapy in patients with HBV-related HCC after curative resection - first announcement of the protocol. Expert Opinion On Biological Therapy. 15: 133-7. PMID 26094695 DOI: 10.1517/14712598.2015.1039979 |
0.4 |
|
| 2015 |
Chen Z, Lu X, Wang Z, Jin G, Wang Q, Chen D, Chen T, Li J, Fan J, Cong W, Gao Q, He X. Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma. Oncotarget. 6: 2538-48. PMID 25576919 |
0.4 |
|
| 2015 |
Cai JB, Shi GM, Dong ZR, Ke AW, Ma HH, Gao Q, Shen ZZ, Huang XY, Chen H, Yu DD, Liu LX, Zhang PF, Zhang C, Hu MY, Yang LX, ... Fan J, et al. Ubiquitin-specific protease 7 accelerates p14(ARF) degradation by deubiquitinating thyroid hormone receptor-interacting protein 12 and promotes hepatocellular carcinoma progression. Hepatology (Baltimore, Md.). 61: 1603-14. PMID 25557975 DOI: 10.1002/hep.27682 |
0.4 |
|
| 2015 |
Liu WR, Tian MX, Yang LX, Lin YL, Jin L, Ding ZB, Shen YH, Peng YF, Gao DM, Zhou J, Qiu SJ, Dai Z, He R, Fan J, Shi YH. PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma. Oncotarget. 6: 846-61. PMID 25514599 |
0.4 |
|
| 2015 |
Dong ZR, Zhang C, Cai JB, Zhang PF, Shi GM, Gao DM, Sun HC, Qiu SJ, Zhou J, Ke AW, Fan J. Role of 5-hydroxymethylcytosine level in diagnosis and prognosis prediction of intrahepatic cholangiocarcinoma. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 36: 2763-71. PMID 25480415 DOI: 10.1007/s13277-014-2900-2 |
0.4 |
|
| 2015 |
Liu WR, Tian MX, Jin L, Yang LX, Ding ZB, Shen YH, Peng YF, Zhou J, Qiu SJ, Dai Z, Fan J, Shi YH. High levels of hepatitis B surface antigen are associated with poorer survival and early recurrence of hepatocellular carcinoma in patients with low hepatitis B viral loads. Annals of Surgical Oncology. 22: 843-50. PMID 25269529 DOI: 10.1245/s10434-014-4043-5 |
0.4 |
|
| 2015 |
Shi JY, Yang LX, Wang ZC, Wang LY, Zhou J, Wang XY, Shi GM, Ding ZB, Ke AW, Dai Z, Qiu SJ, Tang QQ, Gao Q, Fan J. CC chemokine receptor-like 1 functions as a tumour suppressor by impairing CCR7-related chemotaxis in hepatocellular carcinoma. The Journal of Pathology. 235: 546-58. PMID 25255875 DOI: 10.1002/path.4450 |
0.4 |
|
| 2014 |
Ni XC, Yi Y, Fu YP, He HW, Cai XY, Wang JX, Zhou J, Fan J, Qiu SJ. Serum amyloid A is a novel prognostic biomarker in hepatocellular carcinoma. Asian Pacific Journal of Cancer Prevention : Apjcp. 15: 10713-8. PMID 25605163 |
0.4 |
|
| 2014 |
Hu B, Yang XR, Xu Y, Sun YF, Sun C, Guo W, Zhang X, Wang WM, Qiu SJ, Zhou J, Fan J. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 6212-22. PMID 25271081 DOI: 10.1158/1078-0432.CCR-14-0442 |
0.4 |
|
| 2014 |
Gao Q, Yu GY, Shi JY, Li LH, Zhang WJ, Wang ZC, Yang LX, Duan M, Zhao H, Wang XY, Zhou J, Qiu SJ, Jeong LS, Jia LJ, Fan J. Neddylation pathway is up-regulated in human intrahepatic cholangiocarcinoma and serves as a potential therapeutic target. Oncotarget. 5: 7820-32. PMID 25229838 |
0.4 |
|
| 2014 |
Wang JX, Yi Y, Li YW, Cai XY, He HW, Ni XC, Zhou J, Cheng YF, Jin JJ, Fan J, Qiu SJ. Down-regulation of sirtuin 3 is associated with poor prognosis in hepatocellular carcinoma after resection. Bmc Cancer. 14: 297. PMID 24774224 DOI: 10.1186/1471-2407-14-297 |
0.4 |
|
| 2014 |
Liu WR, Tian MX, Jin L, Yang LX, Ding ZB, Shen YH, Peng YF, Zhou J, Qiu SJ, Dai Z, Fan J, Shi YH. High expression of 5-hydroxymethylcytosine and isocitrate dehydrogenase 2 is associated with favorable prognosis after curative resection of hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research : Cr. 33: 32. PMID 24716838 DOI: 10.1186/1756-9966-33-32 |
0.4 |
|
| 2014 |
Tang J, Tao ZH, Wen D, Wan JL, Liu DL, Zhang S, Cui JF, Sun HC, Wang L, Zhou J, Fan J, Wu WZ. MiR-612 suppresses the stemness of liver cancer via Wnt/β-catenin signaling. Biochemical and Biophysical Research Communications. 447: 210-5. PMID 24704424 DOI: 10.1016/j.bbrc.2014.03.135 |
0.4 |
|
| 2014 |
Cai XY, Wang JX, Yi Y, He HW, Ni XC, Zhou J, Cheng YF, Jin JJ, Fan J, Qiu SJ. Low counts of γδ T cells in peritumoral liver tissue are related to more frequent recurrence in patients with hepatocellular carcinoma after curative resection. Asian Pacific Journal of Cancer Prevention : Apjcp. 15: 775-80. PMID 24568494 DOI: 10.7314/APJCP.2014.15.2.775 |
0.4 |
|
| 2014 |
Li YW, Wang JX, Yin X, Qiu SJ, Wu H, Liao R, Yi Y, Xiao YS, Zhou J, Zhang BH, Fan J. Decreased expression of GATA2 promoted proliferation, migration and invasion of HepG2 in vitro and correlated with poor prognosis of hepatocellular carcinoma. Plos One. 9: e87505. PMID 24498120 DOI: 10.1371/journal.pone.0087505 |
0.4 |
|
| 2014 |
Shen YH, Chen S, Peng YF, Shi YH, Huang XW, Yang GH, Ding ZB, Yi Y, Zhou J, Qiu SJ, Fan J, Ren N. Quantitative assessment of the effect of glutathione S-transferase genes GSTM1 and GSTT1 on hepatocellular carcinoma risk. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 35: 4007-15. PMID 24399650 DOI: 10.1007/s13277-013-1524-2 |
0.4 |
|
| 2014 |
Li T, Qin LX, Zhou J, Sun HC, Qiu SJ, Ye QH, Wang L, Tang ZY, Fan J. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection. Liver International : Official Journal of the International Association For the Study of the Liver. 34: 953-60. PMID 24134199 DOI: 10.1111/liv.12364 |
0.4 |
|
| 2013 |
Peng YF, Shi YH, Ding ZB, Ke AW, Gu CY, Hui B, Zhou J, Qiu SJ, Dai Z, Fan J. Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells. Autophagy. 9: 2056-68. PMID 24157892 DOI: 10.4161/auto.26398 |
0.4 |
|
| 2013 |
Peng YF, Shi YH, Shen YH, Ding ZB, Ke AW, Zhou J, Qiu SJ, Fan J. Promoting colonization in metastatic HCC cells by modulation of autophagy. Plos One. 8: e74407. PMID 24058558 DOI: 10.1371/journal.pone.0074407 |
0.4 |
|
| 2013 |
Shi JY, Gao Q, Wang ZC, Zhou J, Wang XY, Min ZH, Shi YH, Shi GM, Ding ZB, Ke AW, Dai Z, Qiu SJ, Song K, Fan J. Margin-infiltrating CD20(+) B cells display an atypical memory phenotype and correlate with favorable prognosis in hepatocellular carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 5994-6005. PMID 24056784 DOI: 10.1158/1078-0432.CCR-12-3497 |
0.4 |
|
| 2013 |
Xiao YS, Gao Q, Xu XN, Li YW, Ju MJ, Cai MY, Dai CX, Hu J, Qiu SJ, Zhou J, Fan J. Combination of intratumoral invariant natural killer T cells and interferon-gamma is associated with prognosis of hepatocellular carcinoma after curative resection. Plos One. 8: e70345. PMID 23940564 DOI: 10.1371/journal.pone.0070345 |
0.4 |
|
| 2013 |
Yin X, Zheng SS, Zhang BH, Zhou Y, Chen XH, Ren ZG, Qiu SJ, Fan J. Elevation of serum γ-glutamyltransferase as a predictor of aggressive tumor behaviors and unfavorable prognosis in patients with intrahepatic cholangiocarcinoma: analysis of a large monocenter study. European Journal of Gastroenterology & Hepatology. 25: 1408-14. PMID 23839159 DOI: 10.1097/MEG.0b013e328364130f |
0.4 |
|
| 2013 |
Liu Y, Zhao YM, Akers W, Tang ZY, Fan J, Sun HC, Ye QH, Wang L, Achilefu S. First in-human intraoperative imaging of HCC using the fluorescence goggle system and transarterial delivery of near-infrared fluorescent imaging agent: a pilot study. Translational Research : the Journal of Laboratory and Clinical Medicine. 162: 324-31. PMID 23747795 DOI: 10.1016/j.trsl.2013.05.002 |
0.4 |
|
| 2013 |
Son YO, Pratheeshkumar P, Wang L, Wang X, Fan J, Kim DH, Lee JY, Zhang Z, Lee JC, Shi X. Reactive oxygen species mediate Cr(VI)-induced carcinogenesis through PI3K/AKT-dependent activation of GSK-3β/β-catenin signaling. Toxicology and Applied Pharmacology. 271: 239-48. PMID 23707771 DOI: 10.1016/j.taap.2013.04.036 |
0.36 |
|
| 2013 |
Zhu K, Pan Q, Zhang X, Kong LQ, Fan J, Dai Z, Wang L, Yang XR, Hu J, Wan JL, Zhao YM, Tao ZH, Chai ZT, Zeng HY, Tang ZY, et al. MiR-146a enhances angiogenic activity of endothelial cells in hepatocellular carcinoma by promoting PDGFRA expression. Carcinogenesis. 34: 2071-9. PMID 23671131 DOI: 10.1093/carcin/bgt160 |
0.4 |
|
| 2013 |
Wang ZC, Gao Q, Shi JY, Yang LX, Zhou J, Wang XY, Shi YH, Ke AW, Shi GM, Ding ZB, Dai Z, Qiu SJ, Fan J. Genetic polymorphism of the kinesin-like protein KIF1B gene and the risk of hepatocellular carcinoma. Plos One. 8: e62571. PMID 23634229 DOI: 10.1371/journal.pone.0062571 |
0.4 |
|
| 2013 |
Liao R, Wu H, Yi Y, Wang JX, Cai XY, He HW, Cheng YF, Zhou J, Fan J, Sun J, Qiu SJ. Clinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research : Cr. 32: 22. PMID 23601182 DOI: 10.1186/1756-9966-32-22 |
0.4 |
|
| 2013 |
Ji J, Yu L, Yu Z, Forgues M, Uenishi T, Kubo S, Wakasa K, Zhou J, Fan J, Tang ZY, Fu S, Zhu H, Jin JG, Sun HC, Wang XW. Development of a miR-26 companion diagnostic test for adjuvant interferon-alpha therapy in hepatocellular carcinoma. International Journal of Biological Sciences. 9: 303-12. PMID 23569435 DOI: 10.7150/ijbs.6214 |
0.4 |
|
| 2013 |
Kong LQ, Zhu XD, Xu HX, Zhang JB, Lu L, Wang WQ, Zhang QB, Wu WZ, Wang L, Fan J, Tang ZY, Sun HC. The clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinoma. Plos One. 8: e59771. PMID 23555776 DOI: 10.1371/journal.pone.0059771 |
0.4 |
|
| 2013 |
Wu H, Chen P, Liao R, Li YW, Yi Y, Wang JX, Cai XY, He HW, Jin JJ, Cheng YF, Fan J, Sun J, Qiu SJ. Intratumoral regulatory T cells with higher prevalence and more suppressive activity in hepatocellular carcinoma patients. Journal of Gastroenterology and Hepatology. 28: 1555-64. PMID 23517245 DOI: 10.1111/jgh.12202 |
0.4 |
|
| 2013 |
Liao R, Sun J, Wu H, Yi Y, Wang JX, He HW, Cai XY, Zhou J, Cheng YF, Fan J, Qiu SJ. High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research : Cr. 32: 3. PMID 23305119 DOI: 10.1186/1756-9966-32-3 |
0.4 |
|
| 2013 |
Yi Y, He HW, Wang JX, Cai XY, Li YW, Zhou J, Cheng YF, Jin JJ, Fan J, Qiu SJ. The functional impairment of HCC-infiltrating γδ T cells, partially mediated by regulatory T cells in a TGFβ- and IL-10-dependent manner. Journal of Hepatology. 58: 977-83. PMID 23262246 DOI: 10.1016/j.jhep.2012.12.015 |
0.4 |
|
| 2013 |
Shi RY, Yang XR, Shen QJ, Yang LX, Xu Y, Qiu SJ, Sun YF, Zhang X, Wang Z, Zhu K, Qin WX, Tang ZY, Fan J, Zhou J. High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery Cancer. 119: 993-1003. PMID 23132676 DOI: 10.1002/cncr.27788 |
0.4 |
|
| 2013 |
Yi Y, Wu H, Gao Q, He HW, Li YW, Cai XY, Wang JX, Zhou J, Cheng YF, Jin JJ, Fan J, Qiu SJ. Interferon regulatory factor (IRF)-1 and IRF-2 are associated with prognosis and tumor invasion in HCC. Annals of Surgical Oncology. 20: 267-76. PMID 22805863 DOI: 10.1245/s10434-012-2487-z |
0.4 |
|
| 2013 |
Li T, Qin LX, Gong X, Zhou J, Sun HC, Qiu SJ, Ye QH, Wang L, Fan J. Hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma: clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence after resection. Cancer. 119: 126-35. PMID 22736338 DOI: 10.1002/cncr.27697 |
0.4 |
|
| 2012 |
Wu MC, Tang ZY, Ye SL, Fan J, Qin SK, Yang JM, Chen MS, Chen MH, Lv MD, Ma KS, Wu YL, Chen Y, Qian GJ, Lu SC, Zheng JS, et al. Expert consensus on local ablation therapies for primary liver cancer. Chinese Clinical Oncology. 1: 11. PMID 25842069 DOI: 10.3978/j.issn.2304-3865.2012.06.01 |
0.4 |
|
| 2012 |
Wang JL, Tao ZH, Wu WZ, Tang J, Sun HC, Wang L, Ren ZG, Fan J. [A nude mouse model of hepatocellular carcinoma single cell-derived organ site-specific metastasis]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 20: 532-6. PMID 23044240 DOI: 10.3760/cma.j.issn.1007-3418.2012.07.011 |
0.4 |
|
| 2012 |
Wang LR, Zhou JM, Zhao YM, He HW, Chai ZT, Wang M, Ji Y, Chen Y, Liu C, Sun HC, Wu WZ, Ye QH, Zhou J, Fan J, Tang ZY, et al. Clinical experience with primary hepatic epithelioid hemangioendothelioma: retrospective study of 33 patients. World Journal of Surgery. 36: 2677-83. PMID 22890877 DOI: 10.1007/s00268-012-1714-x |
0.4 |
|
| 2012 |
Shen Q, Fan J, Yang XR, Tan Y, Zhao W, Xu Y, Wang N, Niu Y, Wu Z, Zhou J, Qiu SJ, Shi YH, Yu B, Tang N, Chu W, et al. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study. The Lancet. Oncology. 13: 817-26. PMID 22738799 DOI: 10.1016/S1470-2045(12)70233-4 |
0.4 |
|
| 2012 |
Sun TW, Gao Q, Qiu SJ, Zhou J, Wang XY, Yi Y, Shi JY, Xu YF, Shi YH, Song K, Xiao YS, Fan J. B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence. Cancer Immunology, Immunotherapy : Cii. 61: 2171-82. PMID 22729558 DOI: 10.1007/s00262-012-1278-5 |
0.4 |
|
| 2012 |
Gao Q, Zhao YJ, Wang XY, Qiu SJ, Shi YH, Sun J, Yi Y, Shi JY, Shi GM, Ding ZB, Xiao YS, Zhao ZH, Zhou J, He XH, Fan J. CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma. Cancer Research. 72: 3546-56. PMID 22710437 DOI: 10.1158/0008-5472.CAN-11-4032 |
0.4 |
|
| 2012 |
Wu H, Chen P, Liao R, Li YW, Yi Y, Wang JX, Sun TW, Zhou J, Shi YH, Yang XR, Jin JJ, Cheng YF, Fan J, Qiu SJ. Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resection. Journal of Gastroenterology and Hepatology. 27: 1312-9. PMID 22432916 DOI: 10.1111/j.1440-1746.2012.07130.x |
0.4 |
|
| 2012 |
Liao R, Sun TW, Yi Y, Wu H, Li YW, Wang JX, Zhou J, Shi YH, Cheng YF, Qiu SJ, Fan J. Expression of TREM-1 in hepatic stellate cells and prognostic value in hepatitis B-related hepatocellular carcinoma. Cancer Science. 103: 984-92. PMID 22417086 DOI: 10.1111/j.1349-7006.2012.02273.x |
0.4 |
|
| 2012 |
Zhao YM, Zhou JM, Wang LR, He HW, Wang XL, Tao ZH, Sun HC, Wu WZ, Fan J, Tang ZY, Wang L. HIWI is associated with prognosis in patients with hepatocellular carcinoma after curative resection. Cancer. 118: 2708-17. PMID 21989785 DOI: 10.1002/cncr.26524 |
0.4 |
|
| 2012 |
Liang Y, Li WW, Yang BW, Tao ZH, Sun HC, Wang L, Xia JL, Qin LX, Tang ZY, Fan J, Wu WZ. Aryl hydrocarbon receptor nuclear translocator is associated with tumor growth and progression of hepatocellular carcinoma. International Journal of Cancer. Journal International Du Cancer. 130: 1745-54. PMID 21544813 DOI: 10.1002/ijc.26166 |
0.4 |
|
| 2011 |
Hu J, Wang Z, Fan J, Dai Z, He YF, Qiu SJ, Huang XW, Sun J, Xiao YS, Song K, Shi YH, Sun QM, Yang XR, Shi GM, Yu L, et al. Genetic variations in plasma circulating DNA of HBV-related hepatocellular carcinoma patients predict recurrence after liver transplantation. Plos One. 6: e26003. PMID 21998744 DOI: 10.1371/journal.pone.0026003 |
0.4 |
|
| 2011 |
Cheng JW, Shi YH, Fan J, Huang XW, Qiu SJ, Xiao YS, Wang Z, Dai Z, Tang ZY, Zhou J. An immune function assay predicts post-transplant recurrence in patients with hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 137: 1445-53. PMID 21809031 DOI: 10.1007/s00432-011-1014-0 |
0.4 |
|
| 2011 |
Shi YH, Ding ZB, Zhou J, Hui B, Shi GM, Ke AW, Wang XY, Dai Z, Peng YF, Gu CY, Qiu SJ, Fan J. Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis. Autophagy. 7: 1159-72. PMID 21691147 DOI: 10.4161/auto.7.10.16818 |
0.4 |
|
| 2011 |
Chen XH, Zhang BH, Xin Y, Ren ZG, Fan J, Qiu SJ, Zhou J. Risk factors for residual tumor after resection of hepatocellular carcinoma. World Journal of Gastroenterology. 17: 1889-94. PMID 21528064 DOI: 10.3748/wjg.v17.i14.1889 |
0.4 |
|
| 2011 |
Xiao CL, Tao ZH, Guo L, Li WW, Wan JL, Sun HC, Wang L, Tang ZY, Fan J, Wu WZ. Isomalto oligosaccharide sulfate inhibits tumor growth and metastasis of hepatocellular carcinoma in nude mice. Bmc Cancer. 11: 150. PMID 21513518 DOI: 10.1186/1471-2407-11-150 |
0.4 |
|
| 2011 |
Tao ZH, Wu WZ, Wang XL, Wan JL, Sun HC, Wang L, Xia JL, Fan J. [The establishment of a systematic site-specific metastasis model of human hepatocellular carcinoma in nude mouse]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 19: 110-3. PMID 21492513 DOI: 10.3760/cma.j.issn.1007-3418.2011.02.009 |
0.4 |
|
| 2011 |
Li T, Fan J, Qin LX, Zhou J, Sun HC, Qiu SJ, Ye QH, Wang L, Tang ZY. Risk factors, prognosis, and management of early and late intrahepatic recurrence after resection of primary clear cell carcinoma of the liver. Annals of Surgical Oncology. 18: 1955-63. PMID 21240562 DOI: 10.1245/s10434-010-1540-z |
0.4 |
|
| 2011 |
Li YW, Qiu SJ, Fan J, Zhou J, Gao Q, Xiao YS, Xu YF. Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection. Journal of Hepatology. 54: 497-505. PMID 21112656 DOI: 10.1016/j.jhep.2010.07.044 |
0.4 |
|
| 2011 |
Xiang ZL, Zeng ZC, Tang ZY, Fan J, Sun HC, Tan YS. Expression of cytokeratin 19 and matrix metalloproteinase 2 predicts lymph node metastasis in hepatocellular carcinoma. Molecular Biology Reports. 38: 3531-9. PMID 21104440 DOI: 10.1007/s11033-010-0463-x |
0.4 |
|
| 2010 |
Xu YF, Yi Y, Qiu SJ, Gao Q, Li YW, Dai CX, Cai MY, Ju MJ, Zhou J, Zhang BH, Fan J. PEBP1 downregulation is associated to poor prognosis in HCC related to hepatitis B infection. Journal of Hepatology. 53: 872-9. PMID 20739083 DOI: 10.1016/j.jhep.2010.05.019 |
0.4 |
|
| 2010 |
Yang XR, Xu Y, Yu B, Zhou J, Qiu SJ, Shi GM, Zhang BH, Wu WZ, Shi YH, Wu B, Yang GH, Ji Y, Fan J. High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma Gut. 59: 953-962. PMID 20442200 DOI: 10.1136/gut.2008.176271 |
0.4 |
|
| 2010 |
Zhou J, Wang Z, Qiu SJ, Huang XW, Sun J, Gu W, Fan J. Surgical treatment for early hepatocellular carcinoma: comparison of resection and liver transplantation. Journal of Cancer Research and Clinical Oncology. 136: 1453-60. PMID 20148264 DOI: 10.1007/s00432-010-0802-2 |
0.4 |
|
| 2010 |
Li WW, Wu WZ, Liang Y, Xiao CL, Tao ZH, Wang L, Sun HC, Fan J. [Effects of ARNT2 gene on invasion and migration of human hepatocellular carcinoma HCCLM6 cell line]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 18: 27-31. PMID 20128965 DOI: 10.3760/cma.j.issn.1007-3418.2010.01.007 |
0.4 |
|
| 2009 |
Dai CX, Gao Q, Qiu SJ, Ju MJ, Cai MY, Xu YF, Zhou J, Zhang BH, Fan J. Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery. Bmc Cancer. 9: 418. PMID 19948069 DOI: 10.1186/1471-2407-9-418 |
0.4 |
|
| 2009 |
Ding ZB, Shi YH, Zhou J, Shi GM, Ke AW, Qiu SJ, Wang XY, Dai Z, Xu Y, Fan J. Liver-intestine cadherin predicts microvascular invasion and poor prognosis of hepatitis B virus-positive hepatocellular carcinoma. Cancer. 115: 4753-65. PMID 19626651 DOI: 10.1002/cncr.24513 |
0.4 |
|
| 2009 |
Cai MY, Xu YF, Qiu SJ, Ju MJ, Gao Q, Li YW, Zhang BH, Zhou J, Fan J. Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 4686-93. PMID 19584149 DOI: 10.1158/1078-0432.CCR-09-0463 |
0.4 |
|
| 2009 |
Zhang N, Wang L, Liang Y, Zhao YM, Xue Q, Wu WZ, Sun HC, Fan J, Tang ZY. The antiangiogenic effects of tyroservatide on animal models of hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 135: 1447-53. PMID 19399517 DOI: 10.1007/s00432-009-0589-1 |
0.4 |
|
| 2009 |
Ju MJ, Qiu SJ, Fan J, Zhou J, Gao Q, Cai MY, Li YW, Tang ZY. Preoperative serum gamma-glutamyl transferase to alanine aminotransferase ratio is a convenient prognostic marker for Child-Pugh A hepatocellular carcinoma after operation. Journal of Gastroenterology. 44: 635-42. PMID 19387533 DOI: 10.1007/s00535-009-0050-x |
0.4 |
|
| 2009 |
Zhou XD, Tang ZY, Ma ZC, Fan J, Wu ZQ, Qin LX, Zhou J, Yu Y, Sun HC, Qiu SJ. Twenty-year survivors after resection for hepatocellular carcinoma-analysis of 53 cases. Journal of Cancer Research and Clinical Oncology. 135: 1067-72. PMID 19294419 DOI: 10.1007/s00432-009-0546-z |
0.4 |
|
| 2009 |
Zhou XD, Tang ZY, Fan J, Zhou J, Wu ZQ, Qin LX, Ma ZC, Sun HC, Qiu SJ, Yu Y, Ren N, Ye QH, Wang L, Ye SL. Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 135: 1073-80. PMID 19294418 DOI: 10.1007/s00432-009-0547-y |
0.4 |
|
| 2009 |
Ju MJ, Qiu SJ, Fan J, Xiao YS, Gao Q, Zhou J, Li YW, Tang ZY. Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection. American Journal of Clinical Pathology. 131: 498-510. PMID 19289585 DOI: 10.1309/AJCP86PPBNGOHNNL |
0.4 |
|
| 2009 |
Li YW, Qiu SJ, Fan J, Gao Q, Zhou J, Xiao YS, Xu Y, Wang XY, Sun J, Huang XW. Tumor-infiltrating macrophages can predict favorable prognosis in hepatocellular carcinoma after resection. Journal of Cancer Research and Clinical Oncology. 135: 439-49. PMID 18781326 DOI: 10.1007/s00432-008-0469-0 |
0.4 |
|
| 2008 |
Ding ZB, Shi YH, Zhou J, Qiu SJ, Xu Y, Dai Z, Shi GM, Wang XY, Ke AW, Wu B, Fan J. Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma. Cancer Research. 68: 9167-75. PMID 19010888 DOI: 10.1158/0008-5472.CAN-08-1573 |
0.4 |
|
| 2008 |
Li T, Wang L, Yu HH, Sun HC, Qin LX, Ye QH, Fan J, Tang ZY. Hepatic angiomyolipoma: a retrospective study of 25 cases. Surgery Today. 38: 529-35. PMID 18516533 DOI: 10.1007/s00595-007-3669-3 |
0.4 |
|
| 2008 |
Shi GM, Xu Y, Fan J, Zhou J, Yang XR, Qiu SJ, Liao Y, Wu WZ, Ji Y, Ke AW, Ding ZB, He YZ, Wu B, Yang GH, Qin WZ, et al. Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials. Journal of Cancer Research and Clinical Oncology. 134: 1155-63. PMID 18470535 DOI: 10.1007/s00432-008-0407-1 |
0.4 |
|
| 2007 |
Sun HC, Zhang W, Qin LX, Zhang BH, Ye QH, Wang L, Ren N, Zhuang PY, Zhu XD, Fan J, Tang ZY. Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma. Journal of Hepatology. 47: 684-90. PMID 17854945 DOI: 10.1016/j.jhep.2007.06.019 |
0.4 |
|
| 2007 |
Li T, Qin LX, Ji Y, Sun HC, Ye QH, Wang L, Pan Q, Fan J, Tang ZY. Atypical hepatic focal nodular hyperplasia presenting as acute abdomen and misdiagnosed as hepatocellular carcinoma. Hepatology Research : the Official Journal of the Japan Society of Hepatology. 37: 1100-5. PMID 17608671 DOI: 10.1111/j.1872-034X.2007.00164.x |
0.4 |
|
| 2005 |
Fan J, Zhou J, Wu ZQ, Qiu SJ, Wang XY, Shi YH, Tang ZY. Efficacy of different treatment strategies for hepatocellular carcinoma with portal vein tumor thrombosis. World Journal of Gastroenterology. 11: 1215-9. PMID 15754408 DOI: 10.3748/WJG.V11.I8.1215 |
0.4 |
|
| 2005 |
Zeng ZC, Tang ZY, Fan J, Zhou J, Qin LX, Ye SL, Sun HC, Wang BL, Zhang JY, Yu Y, Cheng JM, Wang XL, Guo W. Radiation therapy for adrenal gland metastases from hepatocellular carcinoma. Japanese Journal of Clinical Oncology. 35: 61-7. PMID 15709088 DOI: 10.1093/jjco/hyi020 |
0.4 |
|
| 2005 |
Zeng ZC, Fan J, Tang ZY, Zhou J, Qin LX, Wang JH, Sun HC, Wang BL, Zhang JY, Jiang GL, Wang YQ. A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus. International Journal of Radiation Oncology, Biology, Physics. 61: 432-43. PMID 15667964 DOI: 10.1016/j.ijrobp.2004.05.025 |
0.4 |
|
| 2004 |
Zeng ZC, Tang ZY, Fan J, Zhou J, Qin LX, Ye SL, Sun HC, Wang BL, Yu Y, Wang JH, Guo W. A comparison of chemoembolization combination with and without radiotherapy for unresectable hepatocellular carcinoma. Cancer Journal (Sudbury, Mass.). 10: 307-16. PMID 15530260 DOI: 10.1097/00130404-200409000-00008 |
0.4 |
|
| Show low-probability matches. |